FDA rejects claims that lycopene reduces cancer risks
FDA rejects claims that lycopene reduces cancer risks
WASHINGTON -- Tomatoes and/or tomato sauces may reduce the risk of certain cancers, but the Food & Drug Administration has flatly rejected health claims linking lycopene as having any cancer-prevention qualities.
After a two-year review and several delays, FDA ruled on two petitions that asked regulators to allow a wide variety of new health claims regarding eating tomatoes and processed tomato products.
After a two-year review and several delays, FDA ruled on two petitions that asked regulators to allow a wide variety of new health claims regarding eating tomatoes and processed tomato products.